Upload
vudang
View
223
Download
4
Embed Size (px)
Citation preview
Indian Journal of Natural Products and Resources
Vol. 2(1), March 2011, pp. 28-33
Antiurolithiatic activity of Crataeva magna Lour. bark
Suman Kumar Mekap1, Satyaranjan Mishra
2, Sabuj Sahoo
3*and Prasana Kumar Panda
3
1Sri Satya Sai College of Pharmacy, Bhopal-Indore Road, Pachama, Sehore-466 001, Madhya Pradesh, India 2K.V. Virani Institute of Pharmacy & Research Centre, Badhada, Savarkundla-364 515, Gujarat, India
3 Pharmacognosy and Phytochemistry Division, University Department of Pharmaceutical Sciences, Utkal University,
Bhubaneswar -751 004, Orissa, India
Received 25 March 2010; Accepted 18 January 2011
Crataeva magna Lour. bark, commonly known as Baruna, belonging to family Capparaceae, has been investigated for its
antiurolithiatic activity in two conventional models (in vivo) of Urolithiasis in rats. The two methods chosen were lactose (30%)
+ ethylene glycol (1%) and ammonium chloride (2%) + ethylene glycol (0.75%) induced urolithiasis, respectively. The ethanol
extract (400 mg/kg bw) reduced the elevated levels of serum calcium (3.25 ± 0.30) and urine calcium (2.33 ± 0.18) significantly
(P<0.05), employing lactose (30%) + ethylene glycol (1%) induced urolithiasis model. The ethanol extract (400 mg/kg bw)
reduced the urine uric acid level significantly employing both models, viz. lactose (30%) + ethylene glycol (1%) (0.82 ± 0.07;
P<0.001) and ammonium chloride (2%) + ethylene glycol (0.75%) (0.85 ± 0.12; P<0.001) when compared to toxic group. The
ethanol extract (400 mg/kg bw) employing both models resulted in reduced serum creatinine and calcium, urine oxalate and
kidney weight significantly with a marked increase in final body weight and urine volume output when compared to toxic
group. The results shown by the ethanol extract (400 mg/kg bw) group was compared to standard polyherbal drug (Cystone;
5 ml/kg bw) treated group and thus exhibited potent antiurolithiatic activity.
Keywords: Ammonium chloride, Bark, Baruna, Crataeva magna, Ethylene glycol, Lactose, Urolithiasis.
IPC code; Int. cl. (2011.01) A61K 36/18, A61K 129/00, A61P 13/04
Introduction Urolithiasis in its different forms is frequently
encountered during urological complications. Some
common causes are inadequate urinary drainage,
foreign bodies in the urinary tract, microbial infections,
diet with excess oxalates and calcium, vitamin
abnormalities, viz. Vitamin A deficiencies, Vitamin D
excess, metabolic diseases like hyperparathyroidism,
cystinuria, gout and intestinal dysfunction1. Generally
stones of two types i.e., non calcium and calcium
stones are formed2. Calcium, albumin, creatinine, urate
and oxalate are some necessary analytical markers in
serum and urine for clinical diagnosis of this type of
urological disorders3-5
.
In recent times, focus on plant research has
increased all over the world and a large body of
evidence has collected to show immense potential of
medicinal plants used in various traditional systems.
Crataeva magna Lour. bark belonging to family
Capparaceae, has many therapeutic benefits such as
its use in tribal area as antispasmodic, anti-
hypertensive, anti-inflammatory, to treat kidney
stones, anti-hyperglycemic, anti-protozoal, anti-
bacterial, anthelmintic and as an analgesic agent6.
The present study is focused on the investigation of
the antiurolithiatic activity of ethanol and aqueous
extracts of C. magna bark.
Materials and Methods
Collection of plant materials
The bark of C. magna (Plate 1) was collected from
young matured plant from Utkal University campus during the month of May and identified by the Botanist of Department of Botany, Utkal University, Bhubaneswar by comparing with the specimen
present in the Departmental herbarium. After authentification fresh plant materials were collected in bulk, washed under running tap water to remove adhering dust, shade dried and pulverized in a mechanical grinder. The coarse powder was used for further studies.
Extraction
About 200 g of coarse dried powder of bark was
taken in the Soxhlet apparatus and extracted
——————— *Correspondent author: E-mail: [email protected];
Phone: +91-9437344766 (Mob.)
MEKAP et al: ANTIUROLITHIATIC ACTIVITY OF CRATAEVA MAGNA BARK
29
successively using ethanol (95%) and water7,8
. The
extraction for each solvent was carried out for 18 to
20 hours. The extract was collected by evaporating
the solvents and percentage yield was calculated.
Experimental design
Wistar albino rats weighing 140-200 g of either sex were used. The experimental protocol was approved by the Institutional Animal Ethics Committee and animals were maintained under standard conditions for an acclimatization period of 15 days before performing the experiment. All rats were housed individually in metabolic cages and temperature maintained at 22±2°C. The condition in the animal house was approved by Committee for the purpose of Control and Supervision on Experiments on Animals (Regd. No. 990/c/05/CPCSEA). The acute oral toxicity study was done according to OECD guideline at dose range 100 to 4000 mg/kg. No mortality of animals was observed at the dose range and hence two different doses 200 and 400 mg/kg was taken for the study
9.
Lactose (30%) and Ethylene glycol (1%) induced urolithiasis10
Forty two healthy adult Wistar albino strain rats of either sex weighing 140-200 g were randomly divided into seven groups. Each group consists of 6 animals. Group 1: Normal rats were fed with standard rat chow diet and tap water ad libitum for 4 weeks. Group 2: EG intoxicated rats with diet for inducing urolithiasis were fed with a lactose rich Lab diet [the lactose rich lab diet contains: 3.68% sucrose, 30% lactose, 23.4% protein, 10% fat, 5.3% crude fiber, 6.9% ash minerals (calcium 0.95%, phosphorus 0.67%, magnesium 0.21%), vitamin A 22 IU/g, vitamin D3 4.5 IU/g, vitamin E 49 IU/g] with 1% EG (in drinking water)
for 4 weeks. Group 3: (Standard drug treated rats) were fed with lactose rich lab diet + 1% EG + Cystone (5 ml/kg) (Himalaya Lab., India) for 4 weeks. Group 4: test group treated with 200 mg/kg of aqueous extract were fed with lactose rich lab diet + 1% EG + aqueous extract 200 mg/kg for 4 weeks. Group 5: test group treated with 400 mg/kg of aqueous extract were fed with lactose rich lab diet + 1% EG + aqueous extract 400 mg/kg for 4 weeks. Group 6: test group treated with 200 mg/kg of ethanol extract were fed with lactose rich diet + 1% EG + ethanol extract, 200 mg/kg for 4 weeks. Group 7: test group treated with 400 mg/kg of ethanol extract were fed with lactose rich diet + 1% EG + ethanol extract, 400 mg/kg for 4 weeks.
Ammonium chloride (2%) and Ethylene glycol (0.75%) induced
urolithiasis11
Forty two healthy adult Wistar albino strain rats of either sex weighing 140-200 g were randomly divided into seven groups. Each group consisted of 6 animals. The treatment period was considered for 10 days. Group 1: Normal rats were fed with standard rat chow diet and tap water ad libitum for 10 days. Group 2: EG and ammonium chloride intoxicated rats were given normal lab diet + drinking water containing 0.75% [v/v] ethylene glycol (EG) and 2% [w/v] ammonium chloride (AC) for 10 days to induce urolithiasis. Group 3: Standard group were fed with normal lab diet + drinking water containing 0.75% [v/v] EG and 2% [w/v] AC + Cystone (5 ml/kg) for 10 days. Groups 4 and 5: the test groups treated with aqueous extract 200 mg/kg and 400 mg/kg of body weight were fed with normal lab diet + drinking water containing 0.75% [v/v] EG and 2% [w/v] AC with aqueous extract 200 and 400 mg/kg body weight, respectively for 10 days. Groups 6 and 7: the test groups, treated with ethanol extract 200 mg/kg and 400 mg/kg of body weight were fed with normal lab diet + drinking water containing 0.75% [v/v] EG and 2% [w/v] AC with and ethanol extract of C. magna at dose of 200 and 400 mg/kg body weight, respectively for 10 days.
Urine and blood sampling
The crystalluria and stone formation was verified by different biochemical marker analysis of urine and serum. The urine samples of the test animals in different groups were collected in their respective end day of the experiment [on 28
th day in lactose rich diet +
(1%) EG model and on 10th day in (0.75%) EG + (2%)
AC model]. The collected urine sample volume were measured followed by centrifugation at 3000 rpm for
Plate 1―Crataeva magna bark
INDIAN J NAT PROD RESOUR, MARCH 2011
30
10 minutes. After centrifugation the urine samples were examined under light microscope (LAICA, DME Germany 400X) to ensure the presence of oxalate microcrystal followed by biochemical analysis (urine oxalate, calcium and uric acid). The blood samples were collected from the animals under anaesthesia (ether) before sacrificing. The collected blood samples were then centrifuged to obtain serum for the analysis of serum creatinine and serum calcium.
Kidney analysis
The kidney was fixed in bouin liquid12
soaked in paraffin, cut at 3-4 µm intervals and the slices stained using hematoxylene and eosin
13. Tissue
slices were photographed using optical microscopy under polarized light (LAICA, DME Germany 400 X)
Statistical analysis
Results were indicated in terms of mean ± SEM.
Statistical significance of data were assessed by
analysis of variance (One way-ANOVA), followed by
comparison between different groups using ‘Tukey-
Kramer’ multiple comparison test. The significance
was considered at the level of P<0.05.
Results and Discussion
The results of serum and urine biochemistry is
indicated in Tables 1 and 2. Table 1 comprises: the
urine and serum biochemistry data of Lactose (30%)
+ Ethylene glycol (1%) induced urolithiasis model
along with the body weight, urine volume and kidney
weight data. Table 2 comprises: the urine and serum
biochemistry, body weight, urine volume and kidney
weight data of Ammonium chloride (2%) + Ethylene
glycol (0.75%) induced urolithiasis model.
The acute urolithiasis in both the conventional
models was evidenced by the significant elevation in
urine and serum biochemical parameters along with
the reduced urine output as compared to the normal
rats.
The ethanol extract (400 mg/kg bw) employing
Lactose (30%) + Ethylene glycol (1%) induced
urolithiasis resulted a significant reduction (P< 0.001) in
urine uric acid (0.82 ± 0.07) and oxalate (1.54 ± 0.26)
level as compared to toxic group. Serum calcium
(3.25 ± 0.30) and urine calcium (2.33 ± 0.18) level
was significantly (P<0.05) lowered when compared
with the toxic group along with significant elevation
in urine volume (13.38 ± 1.12; P<0.05) output,
However, the extract showed a reduction in serum
creatinine level employing both models but the
reduction is not significant when compared with
urolithic control group.
The ethanol extract (400 mg/kg bw) employing
ammonium chloride (2%) + Ethylene glycol (0.75%)
induced Urolithiasis model exhibited significant
Table 1―Urine and serum biochemistry of 30% lactose and 1% EG induced urolithiasis on 28th day of experiment
Body wt in g Group
I F
Urine volume
in ml
Kidney wt in g Urine
Calcium
mg/dl
Oxalate mg/dl Uric acid Serum
Creatinine
mg/dl
Serum
Calcium
mg/dl
Group 1 172±9.46 191±10.02 18.4±0.97 1.503±0.025 2.25±0.19 0.50±0.03 0.69±0.04 7.45±0.36 4.10±0.21
Group 2 180±6.26 188±6.28 9.96±0.69*** 1.851± 0.035*** 3.27± 0.21* 4.07±0.13*** 1.9±0.10 8.65±0.31 2.21±0.20***
Group 3 182±6.47 195±6.23 14.93±0.57*** 1.618± 0.030*** 2.26± 0.25* 1.21± 0.19*** 0.71±0.04 7.72±0.28 3.48±0.28**
Group 4 186±3.71 195±3.87 10.41±0.45 1.816±0.040 3.10±0.12 3.77±0.28 1.66±0.17 8.50±0.71 2.27±0.21
Group 5 167±4.47 177±4.30 10.9±0.64 1.774±0.030 2.59±0.21 3.24±0.30 1.56± 0.18** 8.04±0.21 2.35±0.17
Group 6 172±3.42 184±2.51 11.5±0.58 1.673± 0.030** 2.75±0.21 2.62± 0.32** 1.36± 0.13*** 8.13±0.58 2.58±0.19
Group 7 189±2.70 204±2.95 13.38±1.12* 1.661± 0.030** 2.33± 0.18* 1.54± 0.26*** 0.82± 0.07*** 7.91±0.71 3.25±0.30*
Values are given in mean ± SEM. *P<0.05, **P<0.01, ***P<0.001. For n=6;
Group 2(Toxic group) was compared with Group 1 (Normal group) and all the other groups were compared with Group 2 (toxic group).
Group 1: Normal control group (Normal lab diet with normal water ad libitum);
Group 2: Urolithic control group (Lactose rich diet + 1% EG in drinking water ad libitum);
Group 3: Standard group (treated with Cystone 5 ml/kg);
Group 4: Treated with aqueous extract 200 mg/kg
Group 5: treated with aqueous extract 400 mg/kg;
Group 6: Treated with ethanol extract 200 mg/kg;
Group 7: Treated with ethanol extract of 400 mg/kg.
I: Initial body weight, F: Final body weight.
MEKAP et al: ANTIUROLITHIATIC ACTIVITY OF CRATAEVA MAGNA BARK
31
reduction in urine uric acid (0.85 ± 0.12; P<0.001),
urine oxalate (2.36 ± 0.42; P<0.01), and serum calcium
(3.29 ± 0.25; P<0.05) level along with significant
elevation in urine volume (12.5 ± 1.0; P< 0.01) output
as compared to toxic rat group.
Ethanol extract 200 mg/kg and the aqueous extracts
200 and 400 mg/kg of body weight in both
the experimental models exhibited minimal
antiurolithiatic activity which was considered below
the significant level.
The results of urine and serum biochemistry
showed significant reduction in urine calcium, uric
acid and oxalate level, serum calcium with significant
elevation in urine volume output, the markers
previously reported which affirmed potent
antiurolithiatic activity14
.
The photomicrograph exhibiting anatomical
changes of kidney is shown in Plate 2 (a-g). The
photo-micrograph of normal control rat kidney (Plate
2a) showing normal organization of tubular
epithelial cells and glomeruli (X-400). Plate 2 (b, c)
represents the section of Urolithic control rat kidney
showing glomerular atrophy and deposition of
crystals (X-400) treated with Lactose rich diet +
(1%) EG in drinking water and (0.75%) EG + (2%)
AC in drinking water, respectively. Plate 2 (d, e)
showing sections of rat kidney treated with standard
cystone (5 ml/kg) showing regenerative changes in
glomeruli and tubules (X-400) employing both
models. The section of rat kidney treated with
ethanol extract 400 mg/kg in 30% lactose + (1%) EG
model and (0.75%) EG + (2%) AC showing
normalcy of tubular epithelial cells and glomeruli
(X-400) is shown in Plate 2 f and g, respectively.
Similar histological observations earlier reported
support the presence of glomerular atrophy and
deposition of crystals and attainment of normalcy of
tubular epithelial cells and glomeruli when treated
with test extract employing both models15
.
The results exhibited by the ethanol extract of
C. magna bark (400 mg/kg bw) in both the
conventional models confirmed its significant
antiurolithiatic potency when compared with the
standard drug (cystone).
Conclusion
The result exhibited by the ethanol extract of
C. magna bark (400 mg/kg bw) showed significant
antiurolithiatic activity. Further studies will be aimed
at extensive investigation, isolation and purification of
active phytoconstituents with potent antiurolithiatic
activity.
Table 2―Urine and serum biochemistry of ammonium chloride 2% and EG 0.75% induced urolithiasis on 10th day of experiment
Body wt in g. Group
I F
Urine volume
in ml
Kidney wt in
g
Urine
Calcium
mg/dl
Oxalate mg/dl Uric acid Serum
Creatinine
mg/dl
Serum
Calcium
mg/dl
Group 1 145±4.28 154±5.14 13.9±1.09 1.516±0.065 2.16±0.15 0.54±0.06 0.61±0.05 7.32±0.53 4.16±0.28
Group 2 168±6.38 156±7.13 7.06±0.58*** 1.621±0.054 3.21±0.19* 4.01± 0.26*** 1.77± 0.17*** 8.16±0.60 2.38± 0.23***
Group 3 158±7.76 164±7.12 12.41±0.98** 1.537±0.062 2.39±0.27 1.44± 0.35*** 0.79± 0.07*** 7.74±0.58 3.7±0.37*
Group 4 173±8.91 163±8.22 8.81±0.78 1.591±0.064 3.33±0.22 3.79±0.18 1.65±0.17 8.07±0.45 2.69±0.17
Group 5 162±5.88 156±5.62 10.38±0.94 1.579±0.049 2.97±0.25 3.61±0.28 1.35±0.12 7.89±0.37 2.71±0.19
Group 6 178±7.70 173±8.68 10.55±1.06 1.589±0.039 2.99±0.18 3.67±0.31 1.26±0.21 8.01±0.25 3.02±0.26
Group 7 175±4.83 180±4.86 12.5±1.0** 1.578±0.046 2.35±0.19 2.36± 0.42** 0.85± 0.12*** 7.49±0.32 3.29±0.25*
Values are given in mean ± SEM. *P<0.05, **P<0.01, ***P<0.001. For n=6;
Group 2(Toxic group) was compared with Group 1 (Normal group) and all the other groups were compared with Group 2 (toxic group).
Group 1: Normal control group (Normal lab diet with normal water ad libitum);
Group 2: Urolithic control group (Normal lab diet with 0.75% EG + 2% AC in drinking water ad libitum);
Group 3: Standard group (treated with Cystone 5 ml/kg);
Group 4: Treated with aqueous extract 200 mg/kg
Group 5: Treated with aqueous extract 400 mg/kg;
Group 6: Treated with ethanol extract 200 mg/kg;
Group 7: Treated with ethanol extract of 400 mg/kg.
I: Initial body weight, F: Final body weight.
INDIAN J NAT PROD RESOUR, MARCH 2011
32
Plate 2 (a-g)―Histological sections of rat kidney; a: Section of normal control rat kidney showing normal organization of tubular
epithelial cells and glomeruli (X-400); b: Section of urolithic control rat (treated with 30% lactose rich diet + 1% EG in drinking water)
kidney showing glomerular atrophy and deposition of crystals (X-400); c: Section of urolithic control rat (treated with 0.75% EG + 2%
AC in drinking water) kidney showing glomerular atrophy and deposition of crystals (X-400); d: Section of standard rat (treated with
cystone; 5 ml/kg) kidney in 30% lactose + 1% EG model, showing regenerative changes in glomeruli and tubules (X-400); e: Section of
standard rat (treated with cystone; 5 ml/kg) kidney in 0.75% EG + 2% AC model, showing regenerative changes in glomeruli and tubules
(X-400); f: Section of rat kidney treated with ethanol extract (400 mg/kg) in 30% lactose + 1% EG model, showing normalcy of tubular
epithelial cells and glomeruli (X-400); g: Section of rat kidney treated with ethanol extract (400 mg/kg) in 0.75% EG + 2% AC model,
showing normalcy of tubular epithelial cells and glomeruli (X-400).
MEKAP et al: ANTIUROLITHIATIC ACTIVITY OF CRATAEVA MAGNA BARK
33
Acknowledgement The authors are thankful to the H.O.D., U.D.P.S.,
Utkal University for providing laboratory facilities.
References 1 Tiselius HG, Etiology and investigation of stone disease.
Curriculum in Urology, Eur Urol, 1998, 2(1), 1-7.
2 Mistry J, Danpure CJ and Chalmers RA, Hepatic D-glycerate
dehydrogenase and glyoxylate reductase deficiency in
primaryhyperoxaluria Type 2, Biochem Soc Trans, 1988, 16,
626-627.
3 Höbarth K, Hofbauer J and Szabo N, Value of repeated
analysis of 24-hour urine in recurrent calcium urolithiasis,
Urology, 1994, 44, 20-25.
4 Hess B, Hasler-Strub U, Ackermann D and Jaeger PH,
Metabolic evaluation of patients with recurrent idiopathic
calcium nephrolithiasis, Nephrol Dial Transplant, 1997, 12,
1362-1368.
5 Tiselius HG, Solution chemistry of supersaturation, In: Kidney Stones: Medical and Surgical Management, by FL Coe, MJ Favus, CYC Pak, HG Parks and GM Preminger (Eds), Lippincott-Raven Publishers, Philadelphia, 1996, pp 31, 33-64.
6 Premila MS, Ayurvedic Herbs: A Clinical Guide to the Healing Plants of Traditional Indian Medicine, In: Plants for urinary tract disorders, 5th Edn, 1995, pp. 157-160.
7 Suftness M and Douras J, Drugs of Plant origin in methods in cancer research, Academic Press, New York, 1979, Vol 2, pp. 548-552.
8 Bhaskar VH, Profulla KM, Balakrishnan BR, Balakrishnan N and Sangameswaran B, Evaluation of the anti-fertility activity of stem bark of Crataeva nurvala Buch.-Ham., Afr
J Biotechnol, 2009, 8 (22), 6453-6456. 9 Smith QE, Pharmacological screening tests progress in
medicinal chemistry, Butterworths, London, 1960, 16, pp. 1-5. 10 Lee YH, Tsai JY and Huang JK, Combined Use of 30%
Lactose Rich Diet and 1% Ethylene Glycol: A New Animal Model for Study of Urolithiasis, J Urol R.O.C., 2000, 11(4), 149-154.
11 Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I,
Eljahiri Y, Oussama A, Grases F and Chait A, Lemon juice
has protective activity in a rat urolithiasis model, BMC
Urology, 2007, 7(18), 2-3.
12 Nolte T, Harleman JH and Jahn W, Histopathology of
chemically induced testicular atrophy in rats, Exp Toxicol
Pathol, 1995, 47, 267-286.
13 Cuzzolin L, Conforti A, Adami A, Lussignoli S, Menestrina
F, Del Soldato P and Benoni G, Anti-inflammatory potency
and gastrointestinal toxicity of a new compound
Nitronaproxen, Pharmacol Res, 1995, 31, 61-65.
14 Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V and
Sathish Kumar AS, Effect of Aerva lanata flowers extract
and Vediuppu chunnam on the urinary risk factors of calcium
oxalate urolithiasis during experimental hyperoxaluria,
Pharmacol Res, 2001, 43, 89-93.
15 Atmani F, Slimani Y, Mimouni M, Aziz M, Hacht B and
Ziyyat A, Effect of aqueous extract from Herniaria hirsuta
L. on experimentally nephrolithiac rats, J Ethnopharmacol,
2004, 95, 87-91